These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23334894)

  • 1. Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice.
    Khan OM; Akula MK; Skålen K; Karlsson C; Ståhlman M; Young SG; Borén J; Bergo MO
    Circulation; 2013 Feb; 127(7):782-90. PubMed ID: 23334894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice.
    Khan OM; Ibrahim MX; Jonsson IM; Karlsson C; Liu M; Sjogren AK; Olofsson FJ; Brisslert M; Andersson S; Ohlsson C; Hultén LM; Bokarewa M; Bergo MO
    J Clin Invest; 2011 Feb; 121(2):628-39. PubMed ID: 21266780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.
    Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK
    Circulation; 2012 Oct; 126(18):2236-47. PubMed ID: 23011471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foam cells in atherosclerosis.
    Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
    Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
    Peng Y; Xu J; Zeng Y; Chen L; Xu XL
    Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
    Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
    Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities.
    Makowski L; Brittingham KC; Reynolds JM; Suttles J; Hotamisligil GS
    J Biol Chem; 2005 Apr; 280(13):12888-95. PubMed ID: 15684432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation.
    Zhou X; Qian J; Hua L; Shi Q; Liu Z; Xu Y; Sang B; Mo J; Yu R
    J Mol Neurosci; 2013 Jan; 49(1):130-9. PubMed ID: 23073905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases.
    Ledford KJ; Murphy N; Zeigler F; Bartel RL
    Stem Cell Res Ther; 2013 Nov; 4(6):135. PubMed ID: 24405662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
    Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
    Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions.
    Akula MK; Ibrahim MX; Ivarsson EG; Khan OM; Kumar IT; Erlandsson M; Karlsson C; Xu X; Brisslert M; Brakebusch C; Wang D; Bokarewa M; Sayin VI; Bergo MO
    Nat Commun; 2019 Sep; 10(1):3975. PubMed ID: 31484924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
    Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
    J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.